MetaCap

Design Therapeutics (DSGN) News

NASDAQ: DSGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.02-0.30 (-3.22%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DSGN news summary

We found 3 recent headlines mentioning Design Therapeutics (DSGN): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. For price context, DSGN is down 3.22% at $9.02. The most recent story, "Design Therapeutics, Inc. Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Nov 4, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Design Therapeutics headlines

Stocks mentioned alongside DSGN

Compare DSGN